Recruiting

Shared Medical Appointments

Sponsor:

Children's Hospital Los Angeles

Code:

NCT06923046

Conditions

Type 2 Diabetes

Eligibility Criteria

Sex: All

Age: 12 - 18

Healthy Volunteers: Not accepted

Interventions

Standard of Care

Shared Medical Appointments

Study Details

Brief summary:

The goal of this clinical trial is to learn if shared medical appointment is an acceptable way to deliver care to youth with type 2 diabetes.

The main question\[s\] it aims to answer are:

  • Is shared medical appointments an acceptable care delivery model for this population?
  • Does shared medical appointment improve psychosocial outcomes for this population?

Participants will attend quarterly clinic appointments and group activities and take surveys. Researchers will compare this intervention to standard of care.

Conditions

Type 2 Diabetes

Study ID

NCT06923046

Start date

Aug 14, 2025

Status verified date

Oct, 2025

Completion date

Jun 30, 2027

Anticipated

Primary completion date

May 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 12 - 18

Healthy Volunteers: Not accepted

Patient/AYA Participants

Inclusion Criteria:

  • Receives care for type 2 diabetes at either CHLA or UCSF
  • English speaking youth
  • Youth prescribed medication for type 2 diabetes
  • English or Spanish speaking caregivers
  • Age 12 to 18 years old at the time of enrollment
  • Willingness to attend clinic visits and participate in group session (if randomized to Team Clinic), complete surveys

Exclusion Criteria:

  • Participants who are non-verbal or unable to participate in group activities and discussions
  • Pregnancy
  • Inability or unwillingness of individual or legal guardian/representative to give written informed assent/consent

Caregiver/Parents Participants

Inclusion Criteria:

  • Has a child between the ages of 12 and up to 18 at the time of enrollment who receives care for T2D in the endocrinology clinic at CHLA. The child must provide consent/assent to participate as a youth participant.
  • Speaks English of Spanish. Over 95% of our T2D population speaks one of those two languages. Our facilitator will be bilingual in English and Spanish. It is not feasible for the facilitator to also speak another language. Having a language interpreter for discussion groups will affect the dynamics and flow of the group session
  • Willingness to participate in group session (if their child is randomized to Team Clinic) and complete surveys.

Exclusion Criteria:

-Inability or unwillingness of individual to give written informed consent

Study Design

Enrollment

160 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

placebo comparator: Standard Care

Multidisciplinary team based care every 3 months.

active comparator: Shared Medical Appointment

Participants will attend 4 quarterly appointments. In addition to time with their clinician, they will also have group activities that address relevant topics.

Interventions

Standard of Care

Multidisciplinary team based care every 3 months.

Shared Medical Appointments

Participants will attend 4 quarterly appointments. In additionto time with their clinician, they will also have groupactivities that address relevant topics.

Primary outcome measure

  • Average number of clinics attended over 1 year period to be recorded by Study Coordinator [ Time Frame: 1 year ]
  • Change in HbA1c for patients from baseline to end of study [ Time Frame: 1 year ]
  • Clinic Satisfaction [ Time Frame: 1 year ]

Central Contacts and Locations

Central contacts

Fatima Aguilar

323-361-4606faguilar@chla.usc.edu

Lily Chao, MD

323-361-4606chao@chla.usc.edu

Locations

Children's Hospital Los Angeles

Recruiting

Los Angeles, California, United States, 91316

Principal Investigator:

Lily Chao, MD, MS

More Information

Sponsor

Children's Hospital Los Angeles

Last update posted

Oct 29, 2025

Last verified

Oct, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Children's Hospital Los Angeles on 2025-10-29.